Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023
24 Oktober 2023 - 10:01PM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that
it will host a conference call and live webcast on Tuesday, October
31, 2023 at 8:30 a.m. Eastern Time to report its third quarter 2023
financial results and recent portfolio execution.
A live webcast will be accessible through the Investors &
Media section of the company’s website at www.kiniksa.com.
Individuals interested in participating in the call via telephone
may register here. Upon registration, all telephone participants
will receive a confirmation email detailing how to join the
conference call, including the dial-in number along with a unique
passcode and registrant ID that can be used to access the call. A
replay of the event will also be available on Kiniksa’s website
within approximately 48 hours after the event.
About KiniksaKiniksa is a biopharmaceutical
company focused on discovering, acquiring, developing, and
commercializing therapeutic medicines for patients suffering from
debilitating diseases with significant unmet medical need.
Kiniksa’s immune-modulating assets, ARCALYST, KPL-404, and
mavrilimumab, are based on strong biologic rationale or validated
mechanisms, target a spectrum of underserved cardiovascular and
autoimmune conditions, and offer the potential for differentiation.
For more information, please visit www.kiniksa.com.
ARCALYST® is a registered trademark of Regeneron
Pharmaceuticals, Inc.
Every Second Counts! ®
Kiniksa Investor and Media ContactRachel
Frank(339) 970-9437rfrank@kiniksa.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
Von Mai 2023 bis Mai 2024